Glenmark Pharmaceuticals informs about media release

24 May 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 24th May 2021, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe’ which is self?explanatory.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1938.35 19.30 (1.01%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×